4D Molecular Therapeutics Inc (FDMT)
Operating Cash Flow Growth
6.20%
TTM · Period ending:
FDMT Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported6.20%period ending
Latest reported6.20%period ending
FDMT TTM Cash from Operations YoY % (-125.89% → 6.20%)
Year-over-year change
High-resolution chart · PNG
FDMT operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 6.2011% | |
| 15.5336% | |
| 18.9494% | |
| -61.853% | |
| -95.4023% | |
| -99.0997% | |
| -77.5715% | |
| -54.5504% | |
| 8.6372% | |
| 15.4513% | |
| 12.5662% | |
| 15.0057% | |
| -15.0486% | |
| -17.7579% | |
| -25.3869% | |
| -33.196% | |
| -29.7276% | |
| -47.511% | |
| -35.7992% | |
| -53.9267% | |
| -57.7662% | |
| -24.797% | |
| -38.6751% | |
| -27.796% | |
| -46.6109% | |
| -94.2058% | |
| -125.886% |